A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents.

ABSTRACT: Rationale: Hepatocellular carcinoma (HCC) is a challenging disease due to its heterogenous etiology. Several breakthroughs have occurred in treatment of HCC, associated with an enormous number of patent publications for a variety of HCC treatment modalities. As patents can provide valuable information for academic research and commercial development, this study aims to unravel the cutting-edge therapies for HCC by using patents as an indicator. The outcome from this analysis may offer meaningful insights for respective policymaking, strategic plan and research and development (R&D) prioritization. Methods: Derwent Innovation platform was employed to collect the sample data of patents related to HCC treatment technologies worldwide as of December 31, 2019. Data inclusion, scre

SUBMITTER: Gao Y 

PROVIDER: S-EPMC8364461 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature